Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors

被引：23
|
作者：
Rosen, LS [1 ]
机构：
[1] Canc Inst Med Grp, Dev Therapeut, Santa Monica, CA 90404 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1053/sonc.2002.37416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 32
页数：5
相关论文
共 50 条
  • [11] Zoledronic acid has broad long-term efficacy in reducing skeletal complications in patients with bone metastases from breast cancer, prostate cancer, and other solid tumors
    Coleman, R
    Rosen, L
    Gleason, DM
    Zheng, M
    BONE, 2004, 34 : S84 - S85
  • [12] Long-term safety of zoledronic acid for the treatment of patients with breast cancer and bone metastases
    Lipton, A.
    Dewar, R.
    Conte, R.
    Zheng, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 142 - 142
  • [13] Effects of zoledronic acid and ibandronate in the treatment of cancer pain in rats with lung cancer combined with bone metastases
    Wang, Gengshen
    Chen, Jiuyi
    Ma, Ruofei
    Xu, Weiyuan
    Yan, Chunlu
    Niu, Cunliang
    ONCOLOGY LETTERS, 2018, 16 (02) : 1696 - 1700
  • [14] Efficacy of zoledronic acid for the prevention of bone metastases in patients with non-small cell lung cancer
    Scagliotti, G
    Manegold, C
    Kosmidis, P
    Kirner, A
    BONE, 2006, 38 (03) : S83 - S83
  • [15] LONG-TERM SAFETY OF ZOLEDRONIC ACID FOR BREAST CANCER WITH BONE METASTASES
    Taira, Shinichiro
    Takahashi, Shunji
    Ito, Yoshinori
    Tokudome, Nahomi
    Tsutsumi, Chizuko
    Kobayashi, Kokoro
    Fukuda, Takayo
    Asai, Hiroaki
    Oto, Masahumi
    Ito, Mayuko
    Hatake, Kiyohiko
    ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [16] Efficacy of zoledronic acid in the treatment of bone metastases secondary to renal cell carcinoma
    Schulman, CC
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (05) : 40 - 45
  • [17] Zoledronic acid treatment in advanced non- small cell lung cancer patients with bone metastases
    Song, Zhengbo
    Zhang, Yiping
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [18] Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases
    Zhengbo Song
    Yiping Zhang
    Medical Oncology, 2014, 31
  • [19] Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
    Lipton, Allan
    Cook, Richard
    Saad, Fred
    Major, Pierre
    Garnero, Patrick
    Terpos, Evangelos
    Brown, Janet E.
    Coleman, Robert E.
    CANCER, 2008, 113 (01) : 193 - 201
  • [20] Zoledronic acid effect on bone metabolic markers in patients with bone metastases due to lung cancer
    Rabinowits, G.
    Janckila, A.
    Yam, L.
    Hendler, F.
    Kloecker, G. H.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 46 - 47
12345